Thompson Davis & Co’s GE HealthCare GEHC Stock Holding History

Thompson Davis & Co’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,457	Closed	-$202K	–	153
2025 Q4	$202K	Buy	+2,457	New	+$191K	0.12%	126
2025 Q2	–	Sell	-2,536	Closed	-$205K	–	149
2025 Q1	$205K	Buy	+2,536	New	+$218K	0.16%	97
2024 Q4	–	Sell	-2,536	Closed	-$238K	–	138
2024 Q3	$238K	Sell	2,536 -2,795	-52%	-$235K	0.18%	93
2024 Q2	$415K	Hold	5,331	–	–	0.36%	48
2024 Q1	$485K	Sell	5,331 -70	-1%	-$5.83K	0.33%	38
2023 Q4	$418K	Hold	5,401	–	–	0.36%	41
2023 Q3	$367K	Buy	5,401 +1,299	+32%	+$94.5K	0.45%	45
2023 Q2	$333K	Buy	4,102 +250	+6%	+$19.9K	0.38%	52
2023 Q1	$316K	Buy	+3,852	New	+$275K	0.41%	52

Other funds holding GEHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Thompson Davis & Co's GEHC Position: Q1 2026 in Review

Thompson Davis & Co sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 2,457 shares — an estimated $202K sold.

Thompson Davis & Co first reported a position in GEHC in Q1 2023 and held it in 9 quarters. The position peaked at $485K in Q1 2024. 1,267 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

Thompson Davis & Co reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
Thompson Davis & Co sold 2,457 GE HealthCare shares in Q1 2026, an estimated $202K.
Thompson Davis & Co first reported a position in GE HealthCare in Q1 2023 and held it in 9 quarters.
Thompson Davis & Co's GE HealthCare position peaked at $485K in Q1 2024.
1,267 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Thompson Davis & Co's 13F filing for Q1 2026, filed 16 Apr 2026.